The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $50.04

Today's change+0.14 +0.28%
Updated July 1 10:29 AM EDT. Delayed by at least 15 minutes.
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $50.04

Today's change+0.14 +0.28%
Updated July 1 10:29 AM EDT. Delayed by at least 15 minutes.

Molina Healthcare Inc up (U.S.)$0.14

Molina Healthcare Inc is up today by (U.S.)$0.14 or 0.28% to (U.S.)$50.04. Over the last five days, shares have lost 0.52% and are down 16.78% for the last year to date. This security has underperformed the S&P 500 by 30.85% during the last year.

Key company metrics

  • Open(U.S.) $49.85
  • Previous close(U.S.) $49.90
  • High(U.S.) $50.05
  • Low(U.S.) $49.36
  • Bid / Ask(U.S.) $50.00 / (U.S.) $50.05
  • YTD % change-16.78%
  • Volume194,712
  • Average volume (10-day)932,331
  • Average volume (1-month)914,440
  • Average volume (3-month)1,074,783
  • 52-week range(U.S.) $44.50 to (U.S.) $82.37
  • Beta1.67
  • Trailing P/E20.32×
  • P/E 1 year forward19.17×
  • Forward PEG0.98×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.46
Updated July 1 10:29 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.90%

Based on its net profit margin of 0.90%, Molina Healthcare Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4,3433,8713,6113,525
Total other revenue--------
Total revenue4,3433,8713,6113,525
Gross profit628568561563
Total cost of revenue3,7153,3033,0502,962
Total operating expense4,2543,7943,4993,409
Selling / general / administrative507463423422
Research & development--------
Depreciation / amortization32282625
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income8976113116
Interest income (expense), net non-operating-25-21-15-15
Gain (loss) on sale of assets--------
Other--------
Income before tax645698101
Income after tax24304639
Income tax, total40275162
Net income24304639
Total adjustments to net income--------
Net income before extra. items24304639
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items24304639
Inc. avail. to common incl. extra. items24304639
Diluted net income24304639
Dilution adjustment--------
Diluted weighted average shares57606050
Diluted EPS excluding extraordinary itemsvalue per share0.420.490.770.77
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.420.490.770.77